Log In
Print
BCIQ
Print
Print this Print this
 

TOBI Podhaler, Tobramycin inhalation powder (TIP)

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionInhaled tobramycin powder
Molecular Target Not applicable
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentApproved
Standard IndicationPseudomonas
Indication DetailsTreat Pseudomonas aeruginosa infection in cystic fibrosis (CF) patients; Treat cystic fibrosis (CF) patients with chronic Pseudomonas lung infection
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today